Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

The Epidemiology of Prostate Cancer

Simone Giona  1
Simon RJ Bott  1 , Keng Lim Ng  1
, editors.
In: Prostate Cancer [Internet]. Brisbane (AU): Exon Publications; 2021 May 27. Chapter 1.
Affiliations
Free Books & Documents
Review

The Epidemiology of Prostate Cancer

Simone Giona.
Free Books & Documents

Excerpt

Prostate cancer is the third most common diagnosed malignancy. It is a heterogeneous disease with incidence rates that vary substantially across the world, from 6.3 to 83.4 per 100,000 people. Age-standardized incidence rates are the highest in Northern Europe and lowest in South Central Asia. Men of African origin are more prone to the disease compared with other ethnicities. Mortality rates differ significantly from incidence rates, with the highest figures in the Caribbean, Sub-Saharan Africa and Micronesia/Polynesia. This chapter provides an overview of the global trends in epidemiology of prostate cancer. Incidence and mortality rates in the Americas, Africa, Europe, Asia, and Oceania are presented.

PubMed Disclaimer

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021 https://doi.org/10.3322/caac.21660. - DOI - PubMed
    1. Baade PD, Youlden DR, Krnjacki LJ. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res. 2009;53(2):171–84. https://doi.org/10.1002/mnfr.200700511. - DOI - PubMed
    1. Surveillance E, and End Results (SEER) Mortality - All COD, Aggregated With State, Total U.S. (1969–2017) <Katrina/Rita Population Adjustment>, National Cancer Institute, DCCPS, Surveillance Research Program, released December 2019. Underlying mortality data provided by NCHS ( www.cdc.gov/nchs) [Accessed on 06 April 2021]
    1. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995;273(7):548–52. https://doi.org/10.1001/jama.1995.03520310046028. - DOI - PubMed
    1. Negoita S, Feuer EJ, Mariotto A, Cronin KA, Petkov VI, Hussey SK, et al. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics. Cancer. 2018;124(13):2801–14. https://doi.org/10.1002/cncr.31549. - DOI - PMC - PubMed

LinkOut - more resources